4.7 Article

5-Bromo-3,4-dihydroxybenzaldehyde stabilizes diabetic retinal neurovascular units by inhibiting the inflammatory microenvironment

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Role of toll-like receptor 4 in diabetic retinopathy

Nikoo Bayan et al.

Summary: Diabetic retinopathy (DR) is a common complication of diabetes mellitus (DM) and is associated with inflammation, cellular apoptosis, neurodegeneration, oxidative stress, and neovascularization. Toll-like receptor 4 (TLR4) plays a crucial role in the development of DR, and microRNAs are involved in the pathogenesis of DR through their interaction with TLR4. Inhibitors of the TLR4 pathway have shown potential in the treatment of DR.

PHARMACOLOGICAL RESEARCH (2022)

Article Pharmacology & Pharmacy

Redoxisome and diabetic retinopathy: Pathophysiology and therapeutic interventions

Isha Sharma et al.

Summary: Diabetic retinopathy (DR) is a major cause of vision loss and blindness in people with diabetes mellitus, and redox reactions play a crucial role in its development. Thioredoxins and thioredoxin-interacting proteins are important regulators of cellular redox homeostasis, and their dysregulation is associated with DR. Understanding the molecular mechanisms and pathophysiological roles of the redoxisome and the TRX/TXNIP redox signaling complex is essential for developing effective treatment strategies for DR.

PHARMACOLOGICAL RESEARCH (2022)

Article Medicine, Research & Experimental

5-Bromo-3,4-dihydroxybenzaldehyde attenuates endothelial cells injury from high glucose-induced damage

Qionghua Wang et al.

Summary: This study found that BDB can protect endothelial cells from damage caused by high glucose, reduce the secretion of inflammatory cytokines, inhibit the activity of NF-kappa B, and decrease ROS production. Furthermore, BDB can preserve the functions of endothelial cells and counteract vascular inflammation induced by hyperglycemia.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Cell Biology

IL-17A injury to retinal ganglion cells is mediated by retinal Muller cells in diabetic retinopathy

Ao-Wang Qiu et al.

Summary: The study suggests that IL-17A plays an important role in diabetic retinopathy by promoting retinal ganglion cell death through retinal Muller cell mediation. Therefore, antagonizing IL-17RA on retinal Muller cells may prevent retinal neuronal death and slow down the progression of DR.

CELL DEATH & DISEASE (2021)

Article Physiology

Microglial Activation Is Associated With Vasoprotection in a Rat Model of Inflammatory Retinal Vasoregression

Sarah Riemann et al.

Summary: Vascular dysfunction and vasoregression are characteristics of various inflammatory central nervous system disorders and inflammation-related retinal diseases. Activation of microglia and the humoral innate immune system play contributing roles. In this study, clodronate treatment led to an increase in activated CD74(+) microglia and prevented acellular capillaries and pericyte loss, indicating a shift towards induction of pleiotropic protective pathways supporting vasoprotection in neurovascular retinal diseases.

FRONTIERS IN PHYSIOLOGY (2021)

Editorial Material Ophthalmology

Anti-VEGF therapy is not a magic bullet for diabetic retinopathy

Mingwei Zhao et al.

Article Cell Biology

Treatment of diabetic retinopathy through neuropeptide Y-mediated enhancement of neurovascular microenvironment

Kepeng Ou et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Review Medicine, Research & Experimental

A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications

Dan-Dan Huang et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Review Medicine, Research & Experimental

The cells involved in the pathological process of diabetic retinopathy

Songtao Yang et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Review Immunology

The Role of Inflammation in Diabetic Retinopathy

John V. Forrester et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Oncology

Restoring retinal neurovascular health via substance P

Kepeng Ou et al.

EXPERIMENTAL CELL RESEARCH (2019)

Review Endocrinology & Metabolism

Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond

Hans-Peter Hammes

DIABETOLOGIA (2018)

Article Biochemistry & Molecular Biology

Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy

Margarida Capitao et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2016)

Review Biochemistry & Molecular Biology

Marine natural products

John W. Blunt et al.

NATURAL PRODUCT REPORTS (2016)

Article Medicine, General & Internal

Diabetic retinopathy

Tien Y. Wong et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Review Chemistry, Medicinal

Bromophenols in Marine Algae and Their Bioactivities

Ming Liu et al.

MARINE DRUGS (2011)

Article Ophthalmology

Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2Akita diabetic mice

Matthew J. Gastinger et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)